Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats

Carcinogenesis

Volumn 19, Issue 9, 1998, Pages 1573-1581

  Sivaraman, Lakshmi ^a   Stephens, L Clifton ^b   Markaverich, Barry M ^a   Clark, James A ^a   Krnacik, Susanne ^a   Conneely, Orla M ^a   O'Malley, Bert W ^a   Medina, Daniel ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CYCLINE; ESTROGEN; ESTROGEN RECEPTOR; METHYLNITROSOUREA; PROGESTERONE; PROGESTERONE RECEPTOR;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; BREAST CELL; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; INCIDENCE; INTRAPERITONEAL DRUG ADMINISTRATION; MATERNAL AGE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RAT; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; BLOTTING, NORTHERN; CELL DIVISION; ESTROGENS; FEMALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; PREGNANCY; PROGESTERONE; RATS; RATS, INBRED WF; RNA, MESSENGER;

EID: 0031717097     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.9.1573     Document Type: Article

References (55)

1. Love, S., Parker, B., Ames, M., Taylor, C., Gilden, R. and Figlin, R.A. (1996) Practice guidelines for breast cancer. Cancer J. Scient. Am., 2, S7-S21.
2. Parker, S.L., Tong, T., Bolden, S. and Wingo, P.A. (1997) Cancer statistics. CA-A Cancer J. Clinic., 47, 5-51.
3. Harris, J.R., Lippman, M.E., Veronesi, U. and Willett, W. (1992) Breast Cancer. Part I. N. Engl. J. Med., 327, 319-328.
4. Kelsy, J.L. and Bernstein, L. (1996) Epidemiology and prevention of breast cancer. Ann. Rev. Publ. Hlth, 17, 47-67.
5. Kelsy, J.L. and Gammon, M.D. (1997) The epidemiology of breast cancer. CA-A Cancer J. Clinic., 41, 146-165.
6. Henderson, B.E., Ross, R.K., Pike, M.C. and Casagrande, J.T. (1982) Endogenous hormones as a major factor in human cancer. Cancer Res., 42, 3232-3239.
7. Key, T.J. and Pike, M.C. (1988) The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur. J. Cancer Clin. Oncol., 24, 29-43.
8. Henderson, B.E., Ross, R.K. and Pike, M.C. (1993) Hormonal chemoprevention of cancer in women. Science, 259, 633-638.
9. Rondinelli, R.H., Haslam, S.Z. and Fluck, M.M. (1995) The role of ovarian hormones, age and mammary gland development in polyomavirus mammary tumorigenesis. Oncogen, 11, 1817-1827.
10. Anderson, E., Clarke, R.B. and Howell, A. (1997) Changes in the normal human breast throughout the menstrual cycle: relevance to breast carcinogenesis. Endocrine-Related Cancer, 4, 23-33.
11. Korach, K.S., Couse, J.R, Curtis, S.W., Washburn, T.F., Lindzey, J., Kimbro, K.S., Eddy, E.M., Migliaccio, S., Snedeker, S.M., Lubahn D.B. et al. (1996) Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Prog. Hormone Res., 51, 159-188.
12. Lydon, J.P., DeMayo, F.J., Funk, C.R., Mani, S.K., Hughes, A.R., Montgomery, C.A. Jr, Shyamala, G., Conneely, O.M. and O'Malley, B.W. (1995) Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev., 9, 2266-2278.
13. Laidlaw, I.J., Clarke, R.B., Howell, A., Owen, A.W., Potten, C.S. and Anderson, E. (1995) The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology, 136, 164-171.
14. Pike, M.C., Spicer, D.V., Dahmoush, L. and Press, M.F. (1993) Estrogens, progestogens, normal breast cell proliferation and breast cancer risk. Epidemiol. Rev., 15, 17-35.
15. MacMahon, B., Cole, P., Lin, T.M., Lowe, C.R., Mirra, A.P., Ravnihar, B., Salber, E.J., Valaoras, V.G. and Yuasa, S. (1970) Age at first birth and breast cancer risk. Bull. World Health Org., 43, 209-221.
16. MacMahon, B., Cole, P. and Brown, J. (1973) Etiology of human breast cancer: a review. J. Natl Cancer Inst., 50, 21-42.
17. De Waard, F. and Trichopoulos, D. (1988) A unifying concept of the aetiology of breast cancer. Int. J. Cancer, 41, 666-669.
18. De Waard, F. (1992) Preventive intervention in breast cancer, but when? Eur. J. Cancer Prev., 1, 395-399.
19. Russo, J., Rivera, R. and Russo, I.H. (1992) Influence of age and parity on the development of the human breast. Breast Cancer Res. Treat., 23, 211-218.
20. Rosner, B., Colditz, G.A. and Willett, W.C. (1994) Reproductive risk factors in a prospective study of breast cancer: the nurses' health study. Am. J. of Epidemiol., 139, 819-835.
21. Moon, R.C. (1969) Relationship between previous reproductive history and chemically-induced mammary cancer in rats. Int. J. Cancer, 4, 312-317.
22. Gullino, P.M., Pettigrew, H.M. and Grantham, F.H. (1975) N-nitrosomethylurea as a mammary gland carcinogen in rats. J. Natl Cancer Inst., 54, 401-414.
23. Haslam, S.Z. (1979) Age as a modifying factor of 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis in the Lewis rat. Int. J. Cancer, 23, 374-379.
24. Russo, J. and Russo, I.H. (1980) Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence. Am. J. Pathol., 100, 497-512.
25. Russo, J. and Russo, I.H. (1982) Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res. Treat., 2, 5-73.
26. Grubbs, C.J., Farnell, D.R., Hill, D.L. and McDonough, K.C. (1985) Chemoprevention of N-nitroso-N-methylurea induced mammary cancers by pretreatment with 17 beta-estradiol and progesterone. J. Natl Cancer Inst., 74, 927-931.
27. Grubbs, C.J., Juliana, M.M. and Whitaker, L.M. (1988) Short-term hormone treatment as a chemopreventive method against mammary cancer initiation in rats. Anticancer Res., 8, 113-117.
28. Sinha, D.K., Pazik, J.E. and Dao, T.L. (1988) Prevention of mammary carcinogenesis in rats by pregnancy: effects of full-term and interrupted pregnancy. Br. J. Cancer, 57, 390-394.
29. Russo, I.H., Koszalka, M. and Russo, J. (1990) Human chorionic gonadotropin and rat mammary cancer prevention. J. Natl Cancer Inst., 82, 1286-1289.
30. Russo, I.H., Koszalka, M. and Russo, J. (1991) Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis. Br. J. Cancer, 64, 481-484.
31. Thordarson, G., Jin, E., Guzman, R.C, Swanson, S.M., Nandi, S. and Talamanter, F. (1995) Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia? Carcinogenesis, 16, 2847-2853.
32. Russo, J. and Russo, I.H. (1997) Role of differentiation in the pathogenesis and prevention of breast cancer. Endocrine-Related Cancer, 4, 7-21.
33. Russo, J. and Russo, I.H. (1980) Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis. Cancer Res., 40, 2677-2687.
34. Tay, L.K. and Russo, J. (1981) 7,12-dimethylbenz[a]anthracene-induced DNA binding and repair synthesis in susceptible and nonsusceptible mammary epithelial cells in culture. J. Natl Cancer Inst., 67, 155-161.
35. Tay, L.K. and Russo, J. (1981) Formation and removal of 7,12-dimethylbenz[a]anthracene-nucleic acid adducts in rat mammary epithelial cells with different susceptibility to carcinogenesis. Carcinogenesis, 2, 1327-1333.
36. Moon, R.C. (1981) Influence of pregnancy and lactation on experimental mammary carcinogenesis. In Pike, M.C., Siiteri, P. and Welch, C.W. (eds) Banbury Report, 8, Hormones and Breast Cancer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 353-364.
37. Rajan, J.V., Marquis, S.T., Gardner, H.P. and Chodosh, L.A. (1997) Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. Dev. Biol., 184, 385-401.
38. Krane, I.M. and Leder, P. (1996) NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice. Oncogene, 12, 1781-1788.
39. Welsch, C.W. and Nagasawa, H. (1977) Prolactin and murine mammary tumorigenesis: a review. Cancer Res., 37, 951-963.
40. Musey, V.C., Collins, D.C., Musey, P.I., Martino-Saltzman, D. and Preedy, J.R. (1987) Long-term effect of a first pregnancy on the secretion of prolactin. N. Engl. J. Med., 316, 229-234.
41. Abrams, T.A., Guzman, R.C., Hirokawa, Y., Swanson, S.M. and Nandi, S. (1997) Refractoriness of parous rats to mammary carcinogenesis is overcome by treatment with ovarian hormones. Proc. 88th Ann. Meet. Am. Ass. Cancer Res., San Diego, CA, p. 297 (Abstract).
42. Isaacs, J.T. (1986) Genetic control of resistance to chemically-induced mammary adenocarcinogenesis in the rat. Cancer Res., 46, 3958-3963.
43. Williams, J.M. and Daniel, C.W. (1983) Mammary ductal elongation: differentiation of myoepithelial and basal lamina during branching morphogenesis. Dev. Biol., 97, 274-290.
44. Gonchoroff, N.J., Greipp, P.R., Kyle, R.A. and Katzmann, J.A. (1985) A monoclonial antibody reactive with 5-bromo-2-deoxyuridine that does not require DNA denaturation. Cytometry, 6, 506-512.
45. Gonchoroff, N.J., Katzmann, J.A., Currie, R.M., Evans, E.L., Houck, D.W., Kline, B.C., Greipp, P.R. and Loken, M.R. (1986) S-phase detection with an antibody to bromodeoxyuridine: Role of DNase pretreatment. J. Immunol. Meth., 93, 97-101.
46. Stephans, L.C., Schultheiss, T.E., Small, S.M., Ang, K.K. and Peters, L.J. (1989) Response of parotid gland organ culture to radiation. Radiat. Res., 120, 140-153.
47. Humphreys, R.C., Krajewska, M., Krnacik, S., Jaeger, R., Weiher, H., Krajewski, S., Reed, J.C. and Rosen, J.M. (1996) Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. Development, 122, 4013-4022.
48. Strange, R., Li, F., Saurer, S., Burkhardt, A. and Friis, R.R. (1992) Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development, 115, 49-58.
49. Pike, M.C., Henderson, B.E. and Casagrande, J.T. (1981) The epidemiology of breast cancer as it relates to menarche, pregnancy, and menopause. In Pike, M.C., Siiteri, P. and Welch, C.W. (eds) Banbury Reports, 8, Hormones and Breast Cancer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 3-19.
50. Russo, I.H., Kozalka, M.S., Gimotty, P.A. and Russo, J. (1990) Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis. Br. J. Cancer, 62, 243-247.
51. Russo, I.H., Kozalka, M. and Russo, J. (1990) Effect of human chorionic gonadotropin on mammary gland differentiation and carcinogenesis. Carcinogenesis, 11, 1849-1855.
52. La Baer, J., Garrett, M.D., Stevenson, L.F., Slingerland, J.M., Sandhu, C., Chou, H.S., Fattaey, A. and Harlow, E. (1997) New functional activities for the p21 family of CDK inhibitors. Genes Dev., 11, 847-862.
53. Herrington, E.E., Ram, T.G., Salomon, D.S., Johnson, G.R., Gullick, W.J., Kenney, N. and Hosick, H.L. (1997) Expression of epidermal growth factor-related proteins in the aged adult mouse mammary gland and their relationship to tumorigenesis. J. Cell. Physiol., 170, 47-56.
54. 32P-postlabeling analysis of the formation and persistence of DNA adducts in mammary glands of parous and nulliparous mice treated with benzo[a]pyrene. Carcinogenesis, 13, 2009-2015.
55. 6-methylguanine-DNA methyltransferase in mammary epithelial cells and liver from virgin, pregnant and pituitary grafted mice. Carcinogenesis, 12, 1795-1800.